2022
Exports
$230MWorld Rnk 33 / 208
Flag Rnk 114 / 1200
2022
PRODUCT COMPLEXITY IN Vaccines, blood, antisera, toxins and cultures
1.38Rnk 75 / 1025
2022
Imports
$3.06BWorld Rnk 19 / 225
Flag Rnk 6 / 1201
2022
ECONOMIC COMPLEXITY of Russia
0.43Rnk 47 / 133

About

Exports In 2022, Russia exported $230M in Vaccines, blood, antisera, toxins and cultures, making it the 33rd largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 114th most exported product in Russia. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Russia are: Kazakhstan ($50.5M), Guatemala ($32.5M), Vietnam ($24.8M), Uzbekistan ($21.8M), and Morocco ($17.2M).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Russia between 2021 and 2022 were Morocco ($13.5M), Indonesia ($6.09M), and South Korea ($3.8M).

Imports In 2022, Russia imported $3.06B in Vaccines, blood, antisera, toxins and cultures, becoming the 19th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 6th most imported product in Russia. Russia imports Vaccines, blood, antisera, toxins and cultures primarily from: Switzerland ($948M), Germany ($531M), Belgium ($422M), Slovenia ($255M), and Austria ($201M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Russia between 2021 and 2022 were Switzerland ($266M), Slovenia ($221M), and Belgium ($189M).

Latest Trends

Oct 2024

Subnational Monthly Trade

View
Flow
Y-AXIS SCALE

For a full breakdown of trade patterns, visit the trend explorer or the product in country profile.

The following visualization shows the latest trends on Vaccines, blood, antisera, toxins and cultures. Countries are shown based on data availability.

* Using January 2020 exchange rates when trade data is reported in local currency.

Explore Latest Trends

Subscribe today to OEC pro and access the latest data

Sign Up

Historical Data

Trade Balance

Color
EXPORTS (2022)$230M
IMPORTS (2022)$3.06B
NET TRADE (2022)-$2.83B

In 2022, Russia exported $230M in Vaccines, blood, antisera, toxins and cultures. The main destinations of Russia exports on Vaccines, blood, antisera, toxins and cultures were Kazakhstan ($50.5M), Guatemala ($32.5M), Vietnam ($24.8M), Uzbekistan ($21.8M), and Morocco ($17.2M).

In 2022, Russia imported $3.06B in Vaccines, blood, antisera, toxins and cultures, mainly from Switzerland ($948M), Germany ($531M), Belgium ($422M), Slovenia ($255M), and Austria ($201M).

Explore Visualizations

Export Destinations (2022)

Import Origins (2022)

Market Growth

Flow
THE FASTEST GROWING Vaccines, blood, antisera, toxins and cultures EXPORT MARKETS FOR Russia WERE (2021 - 2022):
Morocco$13.5M (359%)
Indonesia$6.09M (1%)
South Korea$3.8M (178%)
THE FASTEST DECLINING MARKETS FOR THE EXPORT OF Vaccines, blood, antisera, toxins and cultures BY Russia WERE (2021 - 2022):
Argentina-$209M (-100%)
Mexico-$199M (-100%)
United Arab Emirates-$196M (-99.7%)

Change in Exports by Market (2021 - 2022)

Market Concentration

View
Flow
Type
In 2022, Russia's main exporting competitors in Vaccines, blood, antisera, toxins and cultures were:
In 2022, Russia's main importing competitors in Vaccines, blood, antisera, toxins and cultures were:

Explore Visualizations

Trade Value of Vaccines, blood, antisera, toxins and cultures by Exporters

Potential Exports

Potential Exports

Flow
View
TOP EXPORT POTENTIALUnited States+ $7.05M
TOP IMPORT POTENTIALGermany+ $242M

Vaccines, blood, antisera, toxins and cultures’s highest export potential is United States. With an export gap of $7.05M.   Vaccines, blood, antisera, toxins and cultures’s highest import potential is Germany with an import gap of $242M.

See methodology.

Subscribe today to OEC pro and access the latest data

Sign Up

Have questions, comments, or concerns?
Send us an e-mail: support@oec.world
Follow @OECtoday on
Created, Designed, and Developed by:
In collaboration with